Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Lobular phenotype related to occult-metastatic spread in axillary sentinel node and/or bone marrow in breast carcinoma.

Vincent-Salomon A, Caly M, De Rycke Y, Fréneaux P, Klijanienko J, Laé M, Viard F, Nos C, Bidard FC, Alran S, Salmon R, Kirova Y, Pierga JY, Sigal-Zafrani B, Sastre-Garau X.

Eur J Cancer. 2009 Jul;45(11):1979-86. doi: 10.1016/j.ejca.2009.03.015.

PMID:
19375305
2.

The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.

Gipponi M, Canavese G, Lionetto R, Catturich A, Vecchio C, Sapino A, Friedman D, Cafiero F.

Eur J Surg Oncol. 2006 Mar;32(2):143-7.

PMID:
16300921
3.

Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan.

Yu JC, Hsu GC, Hsieh CB, Sheu LF, Chao TY.

World J Surg. 2005 Jul;29(7):813-8; discussion 818-9.

PMID:
15951935
4.

Comparative analysis of bone marrow micrometastases with sentinel lymph node status in early-stage breast cancer.

Saha S, Ali S, Ghanem M, Soni M, Wiese D, Arora M, Singh T, Iddings D.

Ann Surg Oncol. 2009 Feb;16(2):276-80. doi: 10.1245/s10434-008-0244-0.

PMID:
19050967
5.

Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.

Monti S, Galimberti V, Trifiro G, De Cicco C, Peradze N, Brenelli F, Fernandez-Rodriguez J, Rotmensz N, Latronico A, Berrettini A, Mauri M, Machado L, Luini A, Paganelli G.

Ann Surg Oncol. 2007 Oct;14(10):2928-31.

PMID:
17674108
6.

Tumour vascularity and basement membrane structure in breast cancer as related to tumour histology and prognosis.

Lipponen P, Ji H, Aaltomaa S, Syrjänen K.

J Cancer Res Clin Oncol. 1994;120(11):645-50.

PMID:
7962040
7.

Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.

Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS 3rd.

J Clin Oncol. 2008 Apr 10;26(11):1803-9. doi: 10.1200/JCO.2007.12.6425.

PMID:
18332473
8.

Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?

Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY.

World J Surg. 2009 Jan;33(1):54-7. doi: 10.1007/s00268-008-9782-7.

PMID:
18958521
9.

Association of the presence of bone marrow micrometastases with the sentinel lymph node status in 410 early stage breast cancer patients: results of the Swiss Multicenter Study.

Langer I, Guller U, Koechli OR, Berclaz G, Singer G, Schaer G, Fehr MK, Hess T, Oertli D, Bronz L, Schnarwyler B, Wight E, Uehlinger U, Infanger E, Burger D, Zuber M; Swiss Multicenter Sentinel Lymph Node Study Group in Breast Cancer..

Ann Surg Oncol. 2007 Jun;14(6):1896-903.

PMID:
17356955
10.

Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.

Tunon-de-Lara C, Giard S, Buttarelli M, Blanchot J, Classe JM, Baron M, Monnier B, Houvenaeghel G.

Breast J. 2008 Mar-Apr;14(2):135-40. doi: 10.1111/j.1524-4741.2007.00543.x.

PMID:
18315691
11.

Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone.

Bitter MA, Fiorito D, Corkill ME, Huffer WE, Stemmer SM, Shpall EJ, Archer PG, Franklin WA.

Hum Pathol. 1994 Aug;25(8):781-8.

PMID:
7520018
12.

Detection of cancer cells in the axillary drainage using RT-PCR after operations for breast cancer.

Greenberg R, Barnea Y, Kaplan O, Kashtan H, Skornick Y.

Breast. 2004 Feb;13(1):49-55.

PMID:
14759716
13.

Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?

Chan SW, LaVigne KA, Port ER, Fey JV, Brogi E, Borgen PI, Cody HS 3rd.

Ann Surg. 2008 Jan;247(1):143-9.

PMID:
18156934
15.

Synchronous sentinel lymph node metastasis of lobular and ductal carcinoma.

Mohan D, Mullin BR, Dabbs DJ.

Arch Pathol Lab Med. 2004 Mar;128(3):365. No abstract available.

PMID:
14987139
16.

Wide metastatic spreading in infiltrating lobular carcinoma of the breast.

Ferlicot S, Vincent-Salomon A, Médioni J, Genin P, Rosty C, Sigal-Zafrani B, Fréneaux P, Jouve M, Thiery JP, Sastre-Garau X.

Eur J Cancer. 2004 Feb;40(3):336-41.

PMID:
14746850
17.

PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma.

Buttitta F, Felicioni L, Barassi F, Martella C, Paolizzi D, Fresu G, Salvatore S, Cuccurullo F, Mezzetti A, Campani D, Marchetti A.

J Pathol. 2006 Feb;208(3):350-5.

PMID:
16353168
18.

Distinction between isolated tumor cells and micrometastases in breast cancer: is it reliable and useful?

de Mascarel I, MacGrogan G, Debled M, Brouste V, Mauriac L.

Cancer. 2008 Apr 15;112(8):1672-8. doi: 10.1002/cncr.23368.

19.

Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.

Unal B, Gur AS, Beriwal S, Tang G, Johnson R, Ahrendt G, Bonaventura M, Soran A.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1035-40. doi: 10.1016/j.ijrobp.2008.12.028.

PMID:
19327916
20.

Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

Fougo JL, Afonso M, Senhorães Senra F, Dias T, Leal C, Araújo C, Dinis-Ribeiro M.

Clin Transl Oncol. 2009 Mar;11(3):165-71.

PMID:
19293054

Supplemental Content

Support Center